1197033-18-3 Usage
Uses
Used in Pharmaceutical Industry:
(1R,3R,4R,6S,7S)-3-(6-N-benzoyladenin-9-yl)-1-(4,4'-dimethoxytrityloxymethyl)-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptane is used as a potential pharmaceutical candidate for [application reason]. Its complex structure and multiple chiral centers suggest that it may have unique properties and therapeutic effects that could be beneficial in the development of new drugs.
Used in Organic Synthesis:
In the field of organic synthesis, (1R,3R,4R,6S,7S)-3-(6-N-benzoyladenin-9-yl)-1-(4,4'-dimethoxytrityloxymethyl)-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptane can be used as a key intermediate or building block for the synthesis of other complex organic molecules. Its unique structure and functional groups may enable the development of novel synthetic routes and methodologies.
Used in Biological Research:
(1R,3R,4R,6S,7S)-3-(6-N-benzoyladenin-9-yl)-1-(4,4'-dimethoxytrityloxymethyl)-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptane may also find applications in biological research as a tool compound or probe molecule. Its interaction with biological targets, such as enzymes, receptors, or other macromolecules, could provide valuable insights into the underlying mechanisms of various biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 1197033-18-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,7,0,3 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1197033-18:
(9*1)+(8*1)+(7*9)+(6*7)+(5*0)+(4*3)+(3*3)+(2*1)+(1*8)=153
153 % 10 = 3
So 1197033-18-3 is a valid CAS Registry Number.
1197033-18-3Relevant academic research and scientific papers
Seth, Punit P.,Vasquez, Guillermo,Allerson, Charles A.,Berdeja, Andres,Gaus, Hans,Kinberger, Garth A.,Prakash, Thazha P.,Migawa, Michael T.,Bhat, Balkrishen,Swayze, Eric E.
, p. 1569 - 1581 (2010)
"Chemical Equation Presented" We have recently shown that combining the structural elements of 2′O-methoxyethyl (MOE) and locked nucleic acid (LNA) nucleosides yielded a series of nucleoside modifications (cMOE, 2′,4′-constrained MOE; cEt, 2′,4′-constrain
